Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats

Basit Öğe Kaydı
dc.contributor.authorGedik, Ercan
dc.contributor.authorGirgin, Sadullah
dc.contributor.authorObay, Basra Deniz
dc.contributor.authorOzturk, Hayrettin
dc.contributor.authorOzturk, Hulya
dc.contributor.authorBuyukbayram, Huseyin
dc.date.accessioned2024-04-24T17:18:10Z
dc.date.available2024-04-24T17:18:10Z
dc.date.issued2009
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: To evaluate the effects of iloprost a prostacyclin analogue on the hepatic IR injury in rats. Methods: Forty male Sprague-Dawley rats (250-300 g) were divided into four groups each containing 10 rats; -(1) controls: data from unmanipulated animals; (2) sham group: rats subjected to the surgical procedure, except for liver I/R, and given saline; (3) I/R group: rats that underwent liver ischemia for 45 min followed by reperfusion for 45 min; (4) I-R/Iloprost group: rats pretreated with iloprost (10 mu g kg(-1), i.v). Liver tissues were taken to determine SOD, CAT, GSH, and MDA levels and for biochemical and histological evaluation. Results: The plasma ALT and AST levels were increased in group 3 than in group 4. MDA values and the liver injury score decreased, while the SOD, CAT, and GSH values increased in group 4 compared to group 3. In group 3, hepatocytes were swollen with marked vacuolization. In group 4, there were regular sinusoidal structures with normal morphology without any signs of congestion. Conclusion: We demonstrated hepatoprotective effects of iloprost against severe ischemia and reperfusion injury in rat liver.en_US
dc.identifier.doi10.1590/S0102-86502009000300012
dc.identifier.endpage232en_US
dc.identifier.issn0102-8650
dc.identifier.issn1678-2674
dc.identifier.issue3en_US
dc.identifier.pmid19504007
dc.identifier.scopus2-s2.0-67649760245
dc.identifier.scopusqualityQ2
dc.identifier.startpage226en_US
dc.identifier.urihttps://doi.org/10.1590/S0102-86502009000300012
dc.identifier.urihttps://hdl.handle.net/11468/18642
dc.identifier.volume24en_US
dc.identifier.wosWOS:000266785400012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherActa Cirurgica Brasileiraen_US
dc.relation.ispartofActa Cirurgica Brasileira
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLiveren_US
dc.subjectIschemiaen_US
dc.subjectReperfusionen_US
dc.subjectIloprosten_US
dc.subjectRatsen_US
dc.titleIloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in ratsen_US
dc.titleIloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu